NCT07348107
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07348107
Title ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma. (ATARI-PDAC)
Acronym ATARI-PDAC
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daniel Breadner
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Verspeeten Family Cancer Centre London Ontario N6A 5W9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field